• Elobixibat Hydrate: Expanding IBAT Inhibition to Metabolic M

  2026-07-26

  Explore Elobixibat hydrate, a leading ileal bile acid transporter inhibitor, and its transformative impact on both chronic idiopathic constipation and metabolic regulation. This article delivers novel insights into IBAT inhibition, clinical implications, and practical assay parameters with scientific rigor.

• Drosophila Keap1 Forms Nuclear Condensates in Oxidative Stre

  2026-07-25

  This study demonstrates that Drosophila Keap1 (dKeap1) assembles into nuclear condensates in response to oxidative stress, revealing a previously uncharacterized nuclear function for Keap1 family proteins. The findings provide new mechanistic insight into how dKeap1 domains and intrinsically disordered regions mediate chromatin-associated gene regulation during stress adaptation.

• Anisomycin as a JNK Agonist: Protocols for Apoptosis and Mem

  2026-07-24

  Leverage Anisomycin’s precision as a JNK pathway activator for apoptosis and synaptic plasticity experiments. This article delivers practical protocol enhancements, troubleshooting strategies, and actionable insights from recent breakthroughs in both cancer and neurobiology research.

• Dorsomorphin 2HCl: Translational Leverage in Metabolic Disea

  2026-07-24

  This thought-leadership article explores how Dorsomorphin 2HCl, a potent AMPK and BMP pathway inhibitor, is redefining experimental strategies for translational researchers in metabolic and osteogenic disease. Integrating mechanistic insight with recent evidence from probiotic intervention studies in hepatic lipid accumulation, the article connects molecular rationale, technical protocol parameters, and translational impact—while advancing the conversation beyond standard product guides.

• Nelfinavir Mesylate (SKU A3653): Reliable HIV-1 Protease Inh

  2026-07-23

  This article provides scenario-driven guidance for leveraging Nelfinavir Mesylate (SKU A3653) in cell viability and cytotoxicity workflows. Drawing on recent literature and quantitative benchmarks, we address practical challenges in HIV-1 protease inhibition and ferroptosis research. The analysis highlights APExBIO's offering as a dependable resource for reproducible, high-sensitivity assays.

• Enabling Precision Apoptosis Detection for Translational Bre

  2026-07-23

  This thought-leadership article explores the mechanistic and strategic imperatives for apoptosis and necrosis detection in translational research. Building on the latest mechanistic insights from P2RX1-driven mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), we contextualize the APExBIO Annexin V-Cy5/DAPI Apoptosis Kit as a transformative tool for reliable, high-sensitivity cell death analysis. The narrative integrates competitive landscape analysis, protocol guidance, and a forward-looking perspective on how advanced apoptosis detection underpins the next wave of therapeutic discovery.

• BAF53a as a Prognostic Biomarker and EMT Driver in Glioma

  2026-07-22

  Meng et al. reveal that BAF53a overexpression in glioma predicts poor prognosis and actively drives invasion and epithelial-mesenchymal transition (EMT). Their robust clinical and cellular analyses identify BAF53a as a mechanistically relevant biomarker and potential therapeutic target in aggressive brain tumors.

• Lenalidomide (CC-5013): Enhanced Protocols for Myeloma Resea

  2026-07-22

  Lenalidomide (CC-5013) stands out as a multifaceted immune system activation agent and angiogenesis inhibitor in multiple myeloma research. This article bridges cutting-edge insights on epigenetic synergy with proven protocol enhancements, ensuring optimal experimental outcomes and troubleshooting guidance for translational scientists.

• Nystatin (Fungicidin): Applied Protocols for Antifungal Rese

  2026-07-21

  Nystatin (Fungicidin) from APExBIO empowers researchers to tackle complex Candida and Aspergillus challenges, from cell-based assays to resistance profiling. This article translates latest reference findings and advanced workflows into practical, reproducible protocols and troubleshooting strategies.

• Sodium Orthovanadate: Advanced Control of Phosphorylation St

  2026-07-21

  Explore how Sodium Orthovanadate (Na3VO4) uniquely preserves phosphorylation states in complex metabolic and signaling assays. This article reveals mechanistic insights and practical protocols, distinguishing itself with a deep dive into metabolic pathway regulation and assay design.

• Albiflorin Inhibits RCC Cell Proliferation via EGFR/MAPK Sup

  2026-07-20

  This study integrates experimental and network pharmacology approaches to reveal that albiflorin, a natural compound from Paeonia lactiflora, suppresses renal cell carcinoma (RCC) cell viability, proliferation, and migration. Mechanistic evidence highlights the compound’s modulation of EGFR/MAPK signaling and downregulation of key tumor progression genes, suggesting potential for multi-targeted RCC therapy.

• Q-VD-OPh: Pan-Caspase Inhibitor Workflows for Apoptosis Rese

  2026-07-20

  Q-VD-OPh sets a new benchmark in apoptosis research by enabling precise, reproducible caspase inhibition across in vitro and in vivo systems. Its robust cell and brain permeability, combined with proven efficacy in disease models like Alzheimer’s, empowers advanced experimental design and troubleshooting. Discover how to optimize protocols and interpret anastasis with this APExBIO solution.

• PLK1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-07-19

  This study uncovers how Polo-like kinase 1 (PLK1) directly phosphorylates p31comet to suppress its role in disassembling mitotic checkpoint complexes, thus preventing premature checkpoint inactivation. These findings provide mechanistic insight into cell cycle control and offer a refined understanding for targeting PLK1 in cancer research.

• Charge-Reversed Exosomes Enable mRNA Delivery to Cartilage i

  2026-07-18

  This study introduces charge-reversed, cationic exosomes that penetrate dense cartilage and efficiently deliver mRNA to chondrocytes, addressing major barriers in osteoarthritis gene therapy. The approach achieves intra-tissue depot formation and robust expression of enhanced green fluorescent protein mRNA, with promising implications for targeted, non-viral treatments.

• G007-LK Tankyrase 1/2 Inhibitor: Precision in Wnt Pathway Co

  2026-07-17

  G007-LK brings unprecedented selectivity and nanomolar potency to tankyrase 1/2 inhibition, empowering researchers to dissect Wnt/β-catenin signaling in APC-mutant colorectal and hepatocellular cancer models. Its robust performance, protocol-ready solubility, and data-backed optimization tips make it a cornerstone for reproducible pathway modulation and β-catenin degradation studies.

450 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page